The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 15, 2011

Filed:

Apr. 26, 2007
Applicants:

Joel D. Moore, Somerville, MA (US);

Eric L. Elliott, Brighton, MA (US);

Yat Sun OR, Watertown, MA (US);

Zhe Wang, Hockessin, DE (US);

Inventors:

Joel D. Moore, Somerville, MA (US);

Eric L. Elliott, Brighton, MA (US);

Yat Sun Or, Watertown, MA (US);

Zhe Wang, Hockessin, DE (US);

Assignee:

Enanta Pharmaceuticals, Inc., Watertown, MA (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/395 (2006.01); A61K 31/4965 (2006.01); A61K 31/519 (2006.01); A61K 31/47 (2006.01); A61K 31/41 (2006.01); A01N 43/90 (2006.01); A01N 43/42 (2006.01); A01N 43/64 (2006.01); A01N 43/50 (2006.01); A01N 43/38 (2006.01); C07D 225/00 (2006.01); C07D 295/00 (2006.01); C07D 401/00 (2006.01); C07D 403/00 (2006.01); C07D 405/00 (2006.01); C07D 409/00 (2006.01); C07D 491/00 (2006.01); C07D 495/00 (2006.01); C07D 241/36 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention relates to novel hydrazide-containing compounds of Formula I or Formula II, including pharmaceutically acceptable salts, esters, or prodrugs thereof which inhibit serine protease activity, particularly the activity of hepatitis C virus (HCV) NS3-NS4A protease. Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.


Find Patent Forward Citations

Loading…